Can a breath test or MRI spot asthma Flare-Ups before they start?

NCT ID NCT06317909

Recruiting now Knowledge-focused Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This small study in people with mild allergic asthma aims to see whether non-invasive methods like gas-enhanced MRI and exhaled breath analysis can detect lung inflammation caused by allergens. Participants will undergo both inhaled and segmental (via bronchoscopy) allergen challenges, and researchers will compare results from these new techniques with standard measures like sputum and bronchoalveolar lavage. The goal is to develop better monitoring tools for future asthma treatment trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: allergen challenge (inhaled and segmental)
What this could lead to: If successful, this could lead to simpler, non-invasive ways to monitor asthma inflammation, aiding future drug development.
What could go wrong: This is a very small exploratory study (15 people) focused on method development, not treatment. The techniques may not prove reliable enough for wider use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates